Callitas Health die alte M Pharmaceutical (Seite 33)
eröffnet am 22.09.17 16:18:40 von
neuester Beitrag 28.05.22 09:19:31 von
neuester Beitrag 28.05.22 09:19:31 von
Beiträge: 426
ID: 1.262.481
ID: 1.262.481
Aufrufe heute: 0
Gesamt: 73.083
Gesamt: 73.083
Aktive User: 0
ISIN: CA13125C1068 · WKN: A2GSU1 · Symbol: MPHMF
0,0001
USD
+9.900,00 %
+0,0001 USD
Letzter Kurs 02.03.24 Nasdaq OTC
Werte aus der Branche Pharmaindustrie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,8300 | +161,43 | |
| 9,2900 | +20,96 | |
| 111,75 | +18,87 | |
| 0,6400 | +18,52 | |
| 1,0900 | +14,74 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 4,2400 | -9,59 | |
| 0,5058 | -12,79 | |
| 9,7200 | -19,60 | |
| 14,510 | -32,32 | |
| 8,0000 | -36,76 |
Beitrag zu dieser Diskussion schreiben
Feedback
Callitas Health Announces Addition of Joshua Maurice to Strategic Management Team
Cincinnati, OH, USA (FSCwire) - Callitas Health Inc. (CSE: LILY, OTCQB: MPHMD, FWB: T3F3), (the "Company" or “Callitas”) a clinical-stage company developing innovative technologies for weight management and female health and wellness, today announced that Joshua Maurice has joined the Callitas team as the Director of Sales and Marketing. Within this new role, Mr. Maurice will oversee all worldwide sales and marketing activities related to commercialization of new Callitas products.
"I am excited by the serious commitment Callitas has demonstrated to new innovative health and wellness technologies. With a pipeline of products waiting to reach the market, there could not be a more exciting time to join such a great team and company," Mr. Maurice said. "Callitas offers a great platform for the development of new solutions that will certainly help people live healthier and more productive lives."
Mr. Maurice brings with him over 15 years of consumer goods experience, ranging from women's health care to dietary supplements. Mr. Maurice has overseen and coordinated multi-million dollar marketing campaigns, and has successfully integrated products into some of the largest retailers in the country. Mr. Maurice has brand and private label background expertise, as well as direct response marketing experience, which will greatly help Callitas continue to innovate within the evolving marketplace.
“As our growing portfolio of health solutions continued to expand, we quickly recognized the importance of adding an experienced sales leader to our management team,” said Gary Thompson, President and CEO of Callitas Health. “Joshua is exactly who we needed to bring onboard to concentrate on expanding our current and future distribution of unique products. I’m looking forward to seeing Joshua’s influence on Callitas as he hits the ground running,” added Mr. Thompson.
Additional Callitas News Today
The Company also announced that is has recently granted 750,000 options pursuant to its incentive stock option agreement to directors, officers and employees. These options are exercisable at $0.40 for a period of 5 years.
Cincinnati, OH, USA (FSCwire) - Callitas Health Inc. (CSE: LILY, OTCQB: MPHMD, FWB: T3F3), (the "Company" or “Callitas”) a clinical-stage company developing innovative technologies for weight management and female health and wellness, today announced that Joshua Maurice has joined the Callitas team as the Director of Sales and Marketing. Within this new role, Mr. Maurice will oversee all worldwide sales and marketing activities related to commercialization of new Callitas products.
"I am excited by the serious commitment Callitas has demonstrated to new innovative health and wellness technologies. With a pipeline of products waiting to reach the market, there could not be a more exciting time to join such a great team and company," Mr. Maurice said. "Callitas offers a great platform for the development of new solutions that will certainly help people live healthier and more productive lives."
Mr. Maurice brings with him over 15 years of consumer goods experience, ranging from women's health care to dietary supplements. Mr. Maurice has overseen and coordinated multi-million dollar marketing campaigns, and has successfully integrated products into some of the largest retailers in the country. Mr. Maurice has brand and private label background expertise, as well as direct response marketing experience, which will greatly help Callitas continue to innovate within the evolving marketplace.
“As our growing portfolio of health solutions continued to expand, we quickly recognized the importance of adding an experienced sales leader to our management team,” said Gary Thompson, President and CEO of Callitas Health. “Joshua is exactly who we needed to bring onboard to concentrate on expanding our current and future distribution of unique products. I’m looking forward to seeing Joshua’s influence on Callitas as he hits the ground running,” added Mr. Thompson.
Additional Callitas News Today
The Company also announced that is has recently granted 750,000 options pursuant to its incentive stock option agreement to directors, officers and employees. These options are exercisable at $0.40 for a period of 5 years.
http://www.finanznachrichten.de/nachrichten-aktien/callitas-…
Es ist diese Seite.
Es ist diese Seite.
News !!!
finanzen.net 12:43 Uhr
LG
finanzen.net 12:43 Uhr
LG
Antwort auf Beitrag Nr.: 55.969.374 von Profit2015 am 17.10.17 21:43:35 Das ist immer sehr schwierig einzuschätzen! Das wichtige hier bei diesem Wert ist, dass die Familie Thompson über 50 % der Anteile hält. Dadurch und den Fortschritten bei den Produkten, ist man in einer recht komfortablen Verhandlungsposition
Grüße IMB
Grüße IMB
Schade, dass der Kurs derzeit wieder ein wenig abwärts geht und der Peak nach oben nach der letzten News schon fast wieder abverkauft wurde. Intuitiv würde ich aber eher erwarten, dass es demnächst Richtung Norden geht. Irgendwie hat man das Gefühl, dass es bei dieser Aktie jederzeit eine spektakuläre News geben könnte aufgrund der vielen Eisen, die die Firma im Feuer hat. Bei der mikrigen MK könnten bereits Zahlungen im zweistelligen Millionenbereich den Kurs extrem nach oben katapultieren. natürlich alles sehr spekulativ und High Risk, aber auch sehr interessant. Welches Gefühl habt ihr gerade, wo die Reise hingeht?
Trading Spotlight
Antwort auf Beitrag Nr.: 55.942.541 von IMB2910 am 12.10.17 22:20:40Danke für die schnelle Antwort!
Antwort auf Beitrag Nr.: 55.942.322 von Zukunftsorientiert am 12.10.17 21:55:47Nach den nicht klinischen Studien. Wenn alles glatt läuft 2019.
Antwort auf Beitrag Nr.: 55.941.374 von IMB2910 am 12.10.17 20:16:59Wann wird die Zulassung für C-103 erwartet?
Durchsuchen
